Bruker Corporation (BRKR)
Return on total capital
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 255,300 | 430,200 | 484,900 | 518,600 | 553,500 | 431,600 | 441,800 | 434,100 | 421,100 | 421,400 | 401,600 | 421,800 | 413,300 | 400,700 | 368,700 | 321,000 | 248,300 | 253,200 | 259,800 | 275,400 |
Long-term debt | US$ in thousands | 2,061,800 | 2,264,500 | 2,132,000 | 1,357,300 | 1,160,300 | 1,098,600 | 1,122,500 | 1,109,000 | 1,200,500 | 1,136,800 | 1,171,000 | 1,205,400 | 1,221,800 | 717,500 | 721,100 | 715,800 | 842,300 | 828,200 | 924,200 | 914,800 |
Total stockholders’ equity | US$ in thousands | 1,781,200 | 1,807,000 | 1,789,200 | 1,415,300 | 1,377,200 | 1,208,800 | 1,231,200 | 1,180,300 | 1,113,800 | 937,000 | 970,500 | 1,017,000 | 1,070,500 | 1,075,600 | 1,002,000 | 967,700 | 961,200 | 952,100 | 897,400 | 915,600 |
Return on total capital | 6.64% | 10.57% | 12.37% | 18.70% | 21.81% | 18.71% | 18.77% | 18.96% | 18.20% | 20.32% | 18.75% | 18.98% | 18.03% | 22.35% | 21.40% | 19.07% | 13.77% | 14.22% | 14.26% | 15.05% |
December 31, 2024 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $255,300K ÷ ($2,061,800K + $1,781,200K)
= 6.64%
The return on total capital for Bruker Corporation has shown fluctuations over the analyzed periods. It stood at 15.05% as of March 31, 2020, gradually declining to 13.77% by December 31, 2020. However, a positive trend emerged from March 31, 2021, onwards with significant increases in the return on total capital, reaching a peak of 22.35% by September 30, 2021.
Despite some minor fluctuations in subsequent quarters, the return on total capital generally remained above 18% up to March 31, 2023, indicating efficient capital utilization and profitability. There was a notable spike to 21.81% by December 31, 2023, demonstrating a strong performance in capital allocation.
However, a decline started from June 30, 2024, with the return on total capital dropping to 12.37% and further diminishing to 6.64% by December 31, 2024. The decreasing trend towards the end of the analyzed period suggests a potential impact on the company's overall profitability and effectiveness in generating returns on invested capital.
Overall, while Bruker Corporation showcased periods of strong returns on total capital and improved capital efficiency during the analyzed timeframe, the recent decline calls for a closer examination of the company's capital management strategies to ensure sustained profitability and operational effectiveness in the future.
Peer comparison
Dec 31, 2024